Tumour Necrosis Factor- Blockers in Rheumatoid Arthritis: Review of the Clinical Experience

By Richard-Miceli C.   Dougados M.  

BioDrugs, Vol. 15, Iss. 4, 2001-04 ,pp. : 251-259

Adis International

Access to resources Recommend Favorite

Biologic Therapy for Rheumatoid Arthritis: Clinical Efficacy and Predictors of Response

By Gibbons Laura J.   Hyrich Kimme L.  

BioDrugs, Vol. 23, Iss. 2, 2009-06 ,pp. : 111-124

Adis International

Access to resources Recommend Favorite

Are There Differences in Methotrexate Kinetics Between Responding and Nonresponding Patients with Rheumatoid Arthritis?

By Capone D.  

BioDrugs, Vol. 13, Iss. 5, 2000-05 ,pp. : 373-379

Adis International

Access to resources Recommend Favorite

Adalimumab: A Review of its Use in Adult Patients with Rheumatoid Arthritis

By Cvetković Risto S.   Scott Lesley J.  

BioDrugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 293-311

Adis International

Access to resources Recommend Favorite

Physical activity and pain among patients with rheumatoid arthritis – A cognitive approach

By Lundgren Stina   Olausson Åsa   Bergström Gunnar   Stenström Christina H.  

Advances in Physiotherapy, Vol. 7, Iss. 2, 2005-06 ,pp. : 77-83

Informa Healthcare

Access to resources Recommend Favorite